Download App

Dr. Sharat Damodar

Chairman's Award for Best Doctor

Dr. Sharat Damodar

Vice Chairman, Oncology Services, Narayana Health, Bangalore - MD, DNB, DM (Haemotology, CMC Vellore)

Dr. Sharat Damodar is the Vice Chairman of Oncology Services and Senior Consultant & Head of Adult Haemotology and Bone Marrow Transplantation at the prestigious Narayana Health, Bangalore. Dr. Damodar has extensive experience in treating patients with Leukemia, Lymphomas and Stem Cell Transplantation. He underwent training in Haemotology and Stem Cell Transplantation at Christian Medical College, Vellore and has performed more than 1200 bone marrow and stem cell transplants.

  • Vice Chairman, Oncology Services, Narayana Health, Bangalore

  • Clinical Director, Mazumdar Shaw Medical Center, Narayana Health, Bangalore

  • Chairman's Award for Best Doctor, Narayana Health

  • Bone Marrow Transplantation

  • Stem Cell Transplantation

  • Cord Blood Transplantation

  • Lymphomas

  • Leukemias

  • Blood Disorders

  • Ashok V, Ranganathan R, Chander S, Damodar S, Bhat S, S NK, A SK, Jadav SS, Rajashekaraiah M, T S S. Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases. Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3457-3464

  • Kumar K, Badiger S, Damodar S, Bhat S. Haploidentical Stem cell transplantation with TCR alpha/Beta and CD19 depletion in a case of Unstable Hemoglobin disease. Transplantation. 2018 Feb;102(2):e45-e46. doi: 10.1097/TP.0000000000001986

  • Damodar S, Shanley R, MacMillan M, Ustun C, Weisdorf D. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source. Biol Blood Marrow Transplant. 2017 May;23(5):795-804. doi: 10.1016/j.bbmt.2017.02.009. Epub 2017 Feb 14

  • Kovaleva L, Apte S, Damodar S, Ramanan V, Loriya S, Navarro-Puerto J, Khojasteh A; investigators of the Flebogamma DIF in ITP Study Group. Safety and efficacy of a 10% intravenous immunoglobulin preparation in patients with immune thrombocytopenic purpura: results of two international, multicenter studies. Immunotherapy. 2016. Dec;8(12):1371-1381